2014-2026 Global Anti-Viral Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID :Maia-14687493 | Published Date: 19-Nov-2019 | No. of pages: 120Description
TOC
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2014-2026)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Anti-Viral Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Anti-Viral Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Anti-Viral Drugs Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Anti-Viral Drugs Market-Segmentation by Type
5.1 Hepatitis-C Antivirals
5.2 HIV Antivirals
5.3 Herpes Antivirals
5.4 Hepatitis-B Antivirals
5.5 Influenza Antivirals
5.6 Others (Pneumonia, Flu, etc.)
6 Global Anti-Viral Drugs Market-Segmentation by Application
6.1 Hospitals
6.2 Clinics
6.3 Ambulatory Surgical Centers
7 Global Anti-Viral Drugs Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence – Company Profiles
8.1 Gilead
8.1.1 Gilead Profile
8.1.2 Gilead Sales, Growth Rate and Global Market Share from 2014-2019E
8.1.3 Gilead Product/Solution Launches and Enhancements Analysis
8.1.4 Gilead Business Overview/Recent Development/Acquisitions
8.2 Roche
8.2.1 Roche Profile
8.2.2 Roche Sales, Growth Rate and Global Market Share from 2014-2019E
8.2.3 Roche Product/Solution Launches and Enhancements Analysis
8.2.4 Roche Business Overview/Recent Development/Acquisitions
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Profile
8.3.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2014-2019E
8.3.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.3.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.4 Cipla
8.4.1 Cipla Profile
8.4.2 Cipla Sales, Growth Rate and Global Market Share from 2014-2019E
8.4.3 Cipla Product/Solution Launches and Enhancements Analysis
8.4.4 Cipla Business Overview/Recent Development/Acquisitions
8.5 AstraZeneca
8.5.1 AstraZeneca Profile
8.5.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2014-2019E
8.5.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.5.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.6 Schering-Plough
8.6.1 Schering-Plough Profile
8.6.2 Schering-Plough Sales, Growth Rate and Global Market Share from 2014-2019E
8.6.3 Schering-Plough Product/Solution Launches and Enhancements Analysis
8.6.4 Schering-Plough Business Overview/Recent Development/Acquisitions
8.7 Bristol-Myers-Squibb
8.7.1 Bristol-Myers-Squibb Profile
8.7.2 Bristol-Myers-Squibb Sales, Growth Rate and Global Market Share from 2014-2019E
8.7.3 Bristol-Myers-Squibb Product/Solution Launches and Enhancements Analysis
8.7.4 Bristol-Myers-Squibb Business Overview/Recent Development/Acquisitions
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Profile
8.8.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2014-2019E
8.8.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.8.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.9 Abbott
8.9.1 Abbott Profile
8.9.2 Abbott Sales, Growth Rate and Global Market Share from 2014-2019E
8.9.3 Abbott Product/Solution Launches and Enhancements Analysis
8.9.4 Abbott Business Overview/Recent Development/Acquisitions
8.10 Merck & Co
8.10.1 Merck & Co Profile
8.10.2 Merck & Co Sales, Growth Rate and Global Market Share from 2014-2019E
8.10.3 Merck & Co Product/Solution Launches and Enhancements Analysis
8.10.4 Merck & Co Business Overview/Recent Development/Acquisitions
9 Global Anti-Viral Drugs Market-Segmentation by Geography
10 North America
10.1 North America Anti-Viral Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
10.2 North America Anti-Viral Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
10.3 North America Anti-Viral Drugs Production Analysis from 2014-2019E
10.4 North America Anti-Viral Drugs Consumption Analysis from 2014-2019E
10.5 North America Anti-Viral Drugs Import and Export from 2014-2019E
10.6 North America Anti-Viral Drugs Value, Production and Market Share by Type (2014-2019E)
10.7 North America Anti-Viral Drugs Consumption, Value and Market Share by Application (2014-2019E)
10.8 North America Anti-Viral Drugs by Country (United States, Canada)
10.8.1 North America Anti-Viral Drugs Sales by Country (2014-2019E)
10.8.2 North America Anti-Viral Drugs Consumption Value by Country (2014-2019E)
10.9 North America Anti-Viral Drugs Market PEST Analysis
11 Europe
11.1 Europe Anti-Viral Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
11.2 Europe Anti-Viral Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
11.3 Europe Anti-Viral Drugs Production Analysis from 2014-2019E
11.4 Europe Anti-Viral Drugs Consumption Analysis from 2014-2019E
11.5 Europe Anti-Viral Drugs Import and Export from 2014-2019E
11.6 Europe Anti-Viral Drugs Value, Production and Market Share by Type (2014-2019E)
11.7 Europe Anti-Viral Drugs Consumption, Value and Market Share by Application (2014-2019E)
11.8 Europe Anti-Viral Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Anti-Viral Drugs Sales by Country (2014-2019E)
11.8.2 Europe Anti-Viral Drugs Consumption Value by Country (2014-2019E)
11.9 Europe Anti-Viral Drugs Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Anti-Viral Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
12.2 Asia-Pacific Anti-Viral Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
12.3 Asia-Pacific Anti-Viral Drugs Production Analysis from 2014-2019E
12.4 Asia-Pacific Anti-Viral Drugs Consumption Analysis from 2014-2019E
12.5 Asia-Pacific Anti-Viral Drugs Import and Export from 2014-2019E
12.6 Asia-Pacific Anti-Viral Drugs Value, Production and Market Share by Type (2014-2019E)
12.7 Asia-Pacific Anti-Viral Drugs Consumption, Value and Market Share by Application (2014-2019E)
12.8 Asia-Pacific Anti-Viral Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Anti-Viral Drugs Sales by Country (2014-2019E)
12.8.2 Asia-Pacific Anti-Viral Drugs Consumption Value by Country (2014-2019E)
12.9 Asia-Pacific Anti-Viral Drugs Market PEST Analysis
13 Latin America
13.1 Latin America Anti-Viral Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
13.2 Latin America Anti-Viral Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
13.3 Latin America Anti-Viral Drugs Production Analysis from 2014-2019E
13.4 Latin America Anti-Viral Drugs Consumption Analysis from 2014-2019E
13.5 Latin America Anti-Viral Drugs Import and Export from 2014-2019E
13.6 Latin America Anti-Viral Drugs Value, Production and Market Share by Type (2014-2019E)
13.7 Latin America Anti-Viral Drugs Consumption, Value and Market Share by Application (2014-2019E)
13.8 Latin America Anti-Viral Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Anti-Viral Drugs Sales by Country (2014-2019E)
13.8.2 Latin America Anti-Viral Drugs Consumption Value by Country (2014-2019E)
13.9 Latin America Anti-Viral Drugs Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Anti-Viral Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
14.2 Middle East & Africa Anti-Viral Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
14.3 Middle East & Africa Anti-Viral Drugs Production Analysis from 2014-2019E
14.4 Middle East & Africa Anti-Viral Drugs Consumption Analysis from 2014-2019E
14.5 Middle East & Africa Anti-Viral Drugs Import and Export from 2014-2019E
14.6 Middle East & Africa Anti-Viral Drugs Value, Production and Market Share by Type (2014-2019E)
14.7 Middle East & Africa Anti-Viral Drugs Consumption, Value and Market Share by Application (2014-2019E)
14.8 Middle East & Africa Anti-Viral Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Anti-Viral Drugs Sales by Country (2014-2019E)
14.8.2 Middle East & Africa Anti-Viral Drugs Consumption Value by Country (2014-2019E)
14.9 Middle East & Africa Anti-Viral Drugs Market PEST Analysis
15 Future Forecast of the Global Anti-Viral Drugs Market from 2018-2026
15.1 Future Forecast of the Global Anti-Viral Drugs Market from 2019-2026 Segment by Region
15.2 Global Anti-Viral Drugs Production and Growth Rate Forecast by Type (2019-2026)
15.3 Global Anti-Viral Drugs Consumption and Growth Rate Forecast by Application (2019-2026)
16 Appendix
16.1 Methodology
16.2 Research Data Source
Tables & Figures
List of Tables and Figures
Global Anti-Viral Drugs Market Value ($) and Growth Rate of Anti-Viral Drugs from 2014-2026
Global Anti-Viral Drugs Production and Growth Rate Segment by Product Type from 2014-2026F
Global Anti-Viral Drugs Consumption and Growth Rate Segment by Application from 2014-2019E
Figure Anti-Viral Drugs Picture
Table Product Specifications of Anti-Viral Drugs
Table Driving Factors for this Market
Table Industry News of Anti-Viral Drugs Market
Figure Value Chain Status of Anti-Viral Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Anti-Viral Drugs Production and Growth Rate Segment by Product Type from 2014-2019E
Table Global Anti-Viral Drugs Value ($) and Growth Rate Segment by Product Type from 2014-2019E
Figure Hepatitis-C Antivirals of Anti-Viral Drugs
Figure HIV Antivirals of Anti-Viral Drugs
Figure Herpes Antivirals of Anti-Viral Drugs
Figure Hepatitis-B Antivirals of Anti-Viral Drugs
Figure Influenza Antivirals of Anti-Viral Drugs
Figure Others (Pneumonia, Flu, etc.) of Anti-Viral Drugs
Table Global Anti-Viral Drugs Consumption and Growth Rate Segment by Application from 2014-2019E
Table Global Anti-Viral Drugs Value ($) and Growth Rate Segment by Application from 2014-2019E
Figure Hospitals of Anti-Viral Drugs
Figure Clinics of Anti-Viral Drugs
Figure Ambulatory Surgical Centers of Anti-Viral Drugs
Table Global Anti-Viral Drugs Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E
Table Global Anti-Viral Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E
Figure Traditional Marketing Channel (Offline) of Anti-Viral Drugs
Figure Online Channel of Anti-Viral Drugs
Table Gilead Profile (Company Name, Plants Distribution, Sales Region)
Figure Gilead Sales and Growth Rate from 2014-2019E
Figure Gilead Revenue ($) and Global Market Share from 2014-2019E
Table Gilead Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2014-2019E
Figure Roche Revenue ($) and Global Market Share from 2014-2019E
Table Roche Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2014-2019E
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2014-2019E
Table Johnson & Johnson Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Cipla Profile (Company Name, Plants Distribution, Sales Region)
Figure Cipla Sales and Growth Rate from 2014-2019E
Figure Cipla Revenue ($) and Global Market Share from 2014-2019E
Table Cipla Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2014-2019E
Figure AstraZeneca Revenue ($) and Global Market Share from 2014-2019E
Table AstraZeneca Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Schering-Plough Profile (Company Name, Plants Distribution, Sales Region)
Figure Schering-Plough Sales and Growth Rate from 2014-2019E
Figure Schering-Plough Revenue ($) and Global Market Share from 2014-2019E
Table Schering-Plough Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Bristol-Myers-Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers-Squibb Sales and Growth Rate from 2014-2019E
Figure Bristol-Myers-Squibb Revenue ($) and Global Market Share from 2014-2019E
Table Bristol-Myers-Squibb Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2014-2019E
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2014-2019E
Table GlaxoSmithKline Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Abbott Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Sales and Growth Rate from 2014-2019E
Figure Abbott Revenue ($) and Global Market Share from 2014-2019E
Table Abbott Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Merck & Co Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co Sales and Growth Rate from 2014-2019E
Figure Merck & Co Revenue ($) and Global Market Share from 2014-2019E
Table Merck & Co Anti-Viral Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Global Anti-Viral Drugs Production Value ($) by Region from 2014-2019E
Table Global Anti-Viral Drugs Production Value Share by Region from 2014-2019E
Table Global Anti-Viral Drugs Production by Region from 2014-2019E
Table Global Anti-Viral Drugs Consumption Value ($) by Region from 2014-2019E
Table Global Anti-Viral Drugs Consumption by Region from 2014-2019E
Table North America Anti-Viral Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table North America Anti-Viral Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table North America Anti-Viral Drugs Import and Export from 2014-2019E
Table North America Anti-Viral Drugs Value ($) by Type (2014-2019E)
Table North America Anti-Viral Drugs Production by Type (2014-2019E)
Table North America Anti-Viral Drugs Consumption by Application (2014-2019E)
Table North America Anti-Viral Drugs Consumption by Country (2014-2019E)
Table North America Anti-Viral Drugs Consumption Value ($) by Country (2014-2019E)
Figure North America Anti-Viral Drugs Market PEST Analysis
Table Europe Anti-Viral Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Europe Anti-Viral Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Europe Anti-Viral Drugs Import and Export from 2014-2019E
Table Europe Anti-Viral Drugs Value ($) by Type (2014-2019E)
Table Europe Anti-Viral Drugs Production by Type (2014-2019E)
Table Europe Anti-Viral Drugs Consumption by Application (2014-2019E)
Table Europe Anti-Viral Drugs Consumption by Country (2014-2019E)
Table Europe Anti-Viral Drugs Consumption Value ($) by Country (2014-2019E)
Figure Europe Anti-Viral Drugs Market PEST Analysis
Table Asia-Pacific Anti-Viral Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Asia-Pacific Anti-Viral Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Asia-Pacific Anti-Viral Drugs Import and Export from 2014-2019E
Table Asia-Pacific Anti-Viral Drugs Value ($) by Type (2014-2019E)
Table Asia-Pacific Anti-Viral Drugs Production by Type (2014-2019E)
Table Asia-Pacific Anti-Viral Drugs Consumption by Application (2014-2019E)
Table Asia-Pacific Anti-Viral Drugs Consumption by Country (2014-2019E)
Table Asia-Pacific Anti-Viral Drugs Consumption Value ($) by Country (2014-2019E)
Figure Asia-Pacific Anti-Viral Drugs Market PEST Analysis
Table Latin America Anti-Viral Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Latin America Anti-Viral Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Latin America Anti-Viral Drugs Import and Export from 2014-2019E
Table Latin America Anti-Viral Drugs Value ($) by Type (2014-2019E)
Table Latin America Anti-Viral Drugs Production by Type (2014-2019E)
Table Latin America Anti-Viral Drugs Consumption by Application (2014-2019E)
Table Latin America Anti-Viral Drugs Consumption by Country (2014-2019E)
Table Latin America Anti-Viral Drugs Consumption Value ($) by Country (2014-2019E)
Figure Latin America Anti-Viral Drugs Market PEST Analysis
Table Middle East & Africa Anti-Viral Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Middle East & Africa Anti-Viral Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Middle East & Africa Anti-Viral Drugs Import and Export from 2014-2019E
Table Middle East & Africa Anti-Viral Drugs Value ($) by Type (2014-2019E)
Table Middle East & Africa Anti-Viral Drugs Production by Type (2014-2019E)
Table Middle East & Africa Anti-Viral Drugs Consumption by Application (2014-2019E)
Table Middle East & Africa Anti-Viral Drugs Consumption by Country (2014-2019E)
Table Middle East & Africa Anti-Viral Drugs Consumption Value ($) by Country (2014-2019E)
Figure Middle East & Africa Anti-Viral Drugs Market PEST Analysis
Table Global Anti-Viral Drugs Value ($) and Growth Rate Forecast by Region (2018-2026)
Table Global Anti-Viral Drugs Production and Growth Rate Forecast by Region (2019-2026)
Table Global Anti-Viral Drugs Consumption and Growth Rate Forecast by Region (2019-2026)
Table Global Anti-Viral Drugs Production and Growth Rate Forecast by Type (2019-2026)
Table Global Anti-Viral Drugs Consumption and Growth Rate Forecast by Application (2019-2026)
Companies
- PRICE
-
$3460$5000